G_genetic testing New recommendations from an international consensus conference call for genetic testing of all men with metastatic prostate cancer (PCa) and those with a family history indicative of ...
Despite the clinical utility of biomarker testing in patients with prostate cancer, the tests are infrequently ordered, preventing optimized care. Despite guideline recommendations and the efficacy of ...
A new urology lab with advanced diagnostic testing is up and running at UPMC St. Margaret Hospital to deal with a slow but steady increase in the number of prostate cancer cases diagnosed each year.
BOSTON--(BUSINESS WIRE)--Velsera, a global healthcare technology company offering a universal software platform to connect clinical care with discovery, and Solaris Health, the nation’s leading ...
P4 Diagnostix has teamed with Pierian, a company that provides an analysis platform, to launch somatic testing for patients with prostate cancer. The partnership will further develop P4 Diagnostix’s ...
Clinical practice guidelines do not recommend routine PSA screening in men older than 75 years, men younger than 40 years, or men with a life expectancy of <10 years; however, inappropriate PSA ...
Point of care (POC) testing refers to a laboratory assay that can be performed outside of a centralized facility, with results available to the physician and patient within minutes. One of the most ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results